BVMF/BLAU3 (BVMF/BLAU3)

Brazil Stock Exchange: BVMF/BLAU3 · BRL

R$9.80

+0.01 (+0.1%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	1.8B
Net income (ttm)	233.8M
EPS (ttm)	R$1.01
Shares out	231M
P/E (trailing)	9.7x
P/E (forward)	7.3x
Dividend	R$0.36 (3.62%)
Volume	744,500
Beta	0.44

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 1.8B
Net income (ttm): 233.8M
EPS (ttm): R$1.01
P/E (trailing): 9.7x
P/E (forward): 7.3x
Market cap: 2.3B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E7.3

P25 n/aP50 n/aP75 n/a

Trailing P/E9.7

P25 n/aP50 n/aP75 n/a

ROE10.3

P25 n/aP50 n/aP75 n/a

ROIC10.5

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BVMF/BLAU3 indicators

Market & fundamental data

Available fields

245

Groups with data

Currency

BRL

Showing 245 of 245 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	BRL
Country	Brazil
Country code	BR
Earnings date	2026-11-06
Employees	1,900
Employees change	600
Employees growth	46.15%
Enterprise value	BRL 2.2B
Exchange	Brazil Stock Exchange
Financial currency	BRL
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1987
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	Yes
ISIN number	BRBLAUACNOR8
Last earnings date	2026-08-12
Last refreshed	2026-10-28
Last stock split date	2026-01-06
Last stock split type	Forward
Market cap	BRL 2.3B
Next earnings date	2026-11-06
Price	BRL 9.80
Price currency	BRL
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bvmf/BLAU3
Website	https://www.blau.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	9.59x
Average P/E ratio (5Y)	12.2x
Earnings yield	10.27%
EV/Earnings	9.46x
EV/EBIT	7.17x
EV/EBITDA	6.08x
EV/FCF	9.61x
EV/Sales	1.24x
FCF / EV yield	10.41%
FCF yield	10.18%
Forward P/E	7.33x
Graham number	15.1274
Graham upside	54.52%
Lynch fair value	BRL 5.03
Lynch upside	-48.59%
P/B ratio	0.98x
P/E ratio	9.74x
P/FCF ratio	9.82x
P/OCF ratio	5.33x
P/S ratio	1.27x
PEG ratio	0.45x
Price / tangible book value	1.07x
Price/EBITDA ratio	6.35x
Sector forward P/E	11.33x
Sector P/E	41.97x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	17.28%
EBITDA margin	19.94%
Effective tax rate	21.8%
FCF margin	12.89%
Gross margin	41.34%
Operating margin	17.28%
Pretax margin	16.81%
Profit margin	13.09%
Profit per employee	BRL 123,069
Profitable quarters	38
Profitable years	13
Revenue per employee	BRL 940,067
ROA	5.15%
ROA (5Y)	10.06%
ROCE	9.19%
ROE	10.28%
ROE (5Y)	18.51%
ROIC	10.55%
ROIC (5Y)	20.5%
Tax / revenue	3.66%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-17.06%
EPS growth (Q)	-14.82%
EPS growth (QoQ)	35.29%
EPS growth 3Y	-9.45%
EPS growth 5Y	-8.91%
EPS growth years	0
FCF growth	12.57%
FCF growth (QoQ)	732.58%
FCF growth 3Y	39.09%
FCF growth 5Y	64.97%
Gross profit growth	4.57%
Gross profit growth (Q)	13.28%
Gross profit growth 3Y	7.24%
Gross profit growth 5Y	1.78%
Net income growth	-17.28%
Net income growth (Q)	-15.72%
Net income growth (QoQ)	34.26%
Net income growth 3Y	-9.19%
Net income growth 5Y	-6.93%
Net income growth years	1
OCF growth	4.34%
OCF growth (Q)	475.54%
OCF growth (QoQ)	445.47%
OCF growth 3Y	17.38%
OCF growth 5Y	23.78%
Operating income growth	-26.87%
Operating income growth (Q)	-19.66%
Operating income growth 3Y	-5.37%
Operating income growth 5Y	-8.56%
Revenue growth	1.06%
Revenue growth (Q)	4.68%
Revenue growth (QoQ)	11.87%
Revenue growth 3Y	9.76%
Revenue growth 5Y	5.95%
Revenue growth quarters	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	BRL -194.2M
Depreciation and amortization	BRL 47.5M
EBIT	BRL 308.7M
EBITDA	BRL 356.2M
EPS	BRL 1.01
FCF per share	BRL 1.00
Financing cash flow	BRL 189.1M
Free cash flow	BRL 230.2M
Gross profit	BRL 738.4M
Income taxes	BRL 65.5M
Investing cash flow	BRL -623.8M
Net borrowing	BRL 344.9M
Net cash flow	BRL -12M
Net income	BRL 233.8M
Operating income	BRL 308.7M
Revenue	BRL 1.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.19
Book value per share	BRL 10.10
Debt / EBITDA	2.35
Debt / equity	0.37
Debt / FCF	3.71
Goodwill	BRL 151.7M
Interest coverage	3.62
Long-term assets	BRL 1.9B
Long-term liabilities	BRL 1B
Net cash (debt)	BRL 31.8M
Net cash / market cap	1.41%
Net debt / EBITDA	-0.09
Net debt / equity	-0.01
Net debt / FCF	-0.14
Piotroski F-Score	6
Property, plant and equipment	BRL 986.9M
Shareholders' equity	BRL 2.3B
Tangible book value	BRL 2.1B
Tangible book value per share	BRL 9.15
Total assets	BRL 4B
Total cash	BRL 884.9M
Total debt	BRL 853.1M
Total liabilities	BRL 1.7B
WACC	6.97%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.48
Current assets	BRL 2.2B
Current liabilities	BRL 667.4M
Current ratio	3.23
Inventory turnover	1.58
Net working capital	BRL 845.2M
Quick ratio	2.25
Working capital	BRL 1.5B
Working capital turnover	1.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.27%
Dividend growth	178.22%
Dividend growth (3Y)	8.17%
Dividend growth years	1
Dividend payment date	2028-12-15
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	BRL 0.36
Dividend yield	3.62%
Ex-dividend date	2026-09-30
FCF payout ratio	74.94%
Last dividend	BRL 0.08
Payout ratio	34.19%
Shareholder yield	3.89%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	BRL 10.23
1D price change	0.1%
1M price change	-3.91%
1M total return	-3.34%
1W price change	-22.98%
1W total return	-22.98%
1Y price change	-0.26%
1Y return CAGR	7.35%
1Y total return	7.34%
20-day SMA	BRL 11.70
200-day SMA	BRL 10.20
3M price change	11.97%
3M total return	12.64%
3Y price change	-21.15%
3Y return CAGR	-3.45%
3Y total return	-9.99%
50-day SMA	BRL 10.55
50-day SMA vs 200-day SMA	50over200
52-week high	BRL 13.07
52-week high date	2026-10-21
52-week low	BRL 8.28
52-week low date	2026-08-11
5Y price change	-65.92%
5Y return CAGR	-16.32%
5Y total return	-58.97%
6M price change	-4.01%
6M total return	-2.7%
All-time high	BRL 42.25
All-time high date	2021-07-19
All-time low	BRL 7.08
All-time low date	2024-06-20
Average true range (ATR)	BRL 0.70
Average volume	412.7K
Beta (1Y)	0.6
Beta (2Y)	0.48
Beta (5Y)	0.44
Change from 52-week high	-25.02%
Change from 52-week low	18.36%
Change from all-time high	-76.76%
Change from all-time low	38.76%
Change from open	0.2%
Day's gap	-0.1%
Dollar volume	BRL 7.3M
High price	BRL 9.92
Low price	BRL 9.38
Monthly RSI	45.49
Open price	BRL 9.78
Position in 52-week range	77.78%
Previous close	BRL 9.79
Price vs 150-day SMA	-4%
Price vs 20-day SMA	-16.03%
Price vs 200-day SMA	-3.76%
Price vs 50-day SMA	-6.89%
Relative volume	1.8
RSI	35.02
Sharpe ratio	0.35
Sharpe ratio (3Y)	0.09
Sharpe ratio (5Y)	-0.32
Sortino ratio	0.58
Sortino ratio (3Y)	0.25
Sortino ratio (5Y)	-0.32
Volume	744.5K
Weekly RSI	46.63
YTD price change	-9.14%
YTD total return	-7.21%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	38.6M
Shares change (QoQ)	-0.77%
Shares change (YoY)	-0.27%
Shares held by insiders	83.3%
Shares held by institutions	2.59%
Shares outstanding	231M

Deeper analysis on BVMF/BLAU3

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BVMF/BLAU3 report

Is a complete BVMF/BLAU3 research report available?

No complete published report is available for bvmf/BLAU3 (BVMF/BLAU3) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BVMF/BLAU3 (BVMF/BLAU3)

Price

Financial snapshot

Fair-value bridge

Latest news · BVMF/BLAU3

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BVMF/BLAU3 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BVMF/BLAU3

Frequently asked questions